SynthesisScientific reports2025
Incidence and risk factors associated with ischemic cerebrovascular disease in patients with retinal artery occlusion: a systematic review and meta-analysis.
Synthesis in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Atrial Fibrillation in Retinal Artery Occlusion: A Systematic Review and Meta-Analysis.Medical sciences (Basel, Switzerland) · 2026Pooled it
- Smoking and Risk of Vision Threatening Complications: A Global Database Analysis.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the incidence of ischemic cerebrovascular disease (CVD), including ischemic stroke, silent stroke, and transient ischemic attack (TIA) or amaurosis fugax (AF), in patients with retinal artery occlusion (RAO). Subgroup analyses focus on RAO type and study site, exploring the association between stroke occurrence and RAO types, alongside potential stroke risk factors. Two authors independently conducted a systematic review of PubMed, Embase, and SCOPUS databases adhering to PRISMA guidelines. Our PROSPERO registration number is CRD42022354977. The analysis of 101,952 patients in 46 studies, revealed a high incidence of ischemic CVD in RAO patients:13.6% (11.5-15.9) overall, 14.4% (11.4-18.0) central retinal artery occlusion (CRAO), and 22.2% (13.5-34.3) branch retinal artery occlusion (BRAO). Patients with CRAO had a higher risk of ischemic CVD, OR 1.59 (1.45-1.75) compared to BRAO. Patients with RAO had an OR of 2.75 (2.11-3.58) for ischemic CVD compared to non-RAO patients. Risk factors significantly associated with ischemic CVD in RAO patients included smoking (OR 1.16), atrial fibrillation (OR 1.32), dyslipidemia (OR 1.30), chronic heart failure (OR 1.51), and valvular heart disease (OR 1.60). These findings highlight the need for rigorous stroke screening, close monitoring, and aggressive management of modifiable risk factors in RAO patients to reduce their stroke risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.